These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 3381222

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H, Sharabi FM, O'Connor G, Mark AL, Schmid PG.
    Clin Exp Hypertens A; 1982; 4(8):1303-21. PubMed ID: 7116668
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Contribution of vasopressin to the maintenance of blood pressure in deoxycorticosterone-salt induced malignant hypertension in spontaneously hypertensive rats.
    Hiwatari M, Abrahams JM, Saito T, Johnston CI.
    Clin Sci (Lond); 1986 Feb; 70(2):191-8. PubMed ID: 3956109
    [Abstract] [Full Text] [Related]

  • 7. Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension.
    Crofton JT, Share L, Wang BC, Shade RE.
    Hypertension; 1980 Feb; 2(4):424-31. PubMed ID: 7399626
    [Abstract] [Full Text] [Related]

  • 8. Contributions of vasopressin and other pressor systems to DOC-salt hypertension in rats.
    Mento PF, Wang HH, Sawyer WH.
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):58-63. PubMed ID: 6694969
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vasopressin and sympathetic nervous functions both contribute to development and maintenance of hypertension in DOCA-salt rats.
    Takata Y, Yamashita Y, Takishita S, Fujishima M.
    Clin Exp Hypertens A; 1988 Jan; 10(2):203-27. PubMed ID: 3370846
    [Abstract] [Full Text] [Related]

  • 11. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats.
    Larivière R, St-Louis J, Schiffrin EL.
    J Hypertens; 1988 Mar; 6(3):211-7. PubMed ID: 3283226
    [Abstract] [Full Text] [Related]

  • 12. Chlorthalidone alters the vascular reactivity of DOC-salt hypertensive rats to norepinephrine.
    Musso MN, Vasquez EC, Carvalhinho FB, Bissoli NS, Cabral AM.
    Braz J Med Biol Res; 1990 Mar; 23(10):999-1003. PubMed ID: 2101067
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Responses of mean arterial pressure to pressor agents and diuretics in renal hypertensive and salt hypertensive rats.
    Nicholas TE.
    Br J Pharmacol; 1971 Jun; 42(2):179-92. PubMed ID: 4326321
    [Abstract] [Full Text] [Related]

  • 18. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats.
    Deng LY, Schiffrin EL.
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1782-7. PubMed ID: 1621836
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.